Optimizing outcomes in hepatitis C: is treatment beyond 48 weeks ever justified?
Fontana
Robert J
RJ
D000998:Antiviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D055502:Secondary Prevention
D000998:Antiviral Agents